GPT and blood coagulation disease: In our study, we found that an AST/ALT ratio > 1.9 accelerated the development of adverse outcomes in patients with HBV-associated advanced fibrosis, especially those with severe jaundice and/or coagulopathy, and that an elevated AST/ALT ratio was a high-risk factor for such outcomes.